September 10, 2025CancersOpen Access

The RNA-Binding Protein RBMX Mediates the Immunosuppressive Microenvironment of Osteosarcoma by Regulating CD8+T Cells

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis shows RBMX influences CD8+T cell activity in osteosarcoma, suggesting immunotherapy targets.

RBMX deletion significantly enhanced the cytotoxic activity of CD8+T cells, improving antitumor responses.
High RBMX expression in osteosarcoma correlates with poor prognosis and mediates an immunosuppressive microenvironment.
Single-cell transcriptome sequencing revealed RBMX's effects on T cell recruitment in the tumor microenvironment.
Knockout of RBMX upregulated H2-K1 and downregulated THBS1, potentially reshaping the immune response in osteosarcoma.

Qiu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark